Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

In recent weeks there has been a buzz around a new treatment breakthrough: benralizumab, which in a study published in the ...

Researchers in the UK say that AstraZeneca's benralizumab can have a dramatic impact if used to treat acute asthma attacks, calling it the first major advance for this aspect of the disease in 50 ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

Earlier this year, researchers of Brigham and Women’s Hospital Harvard Medical School looked at clinical trials to show how six biologics, in particular, improve lung function; cut down on steroid use ...

The editor’s pick for this issue is a review article discussing the promise of hyperpolarised xenon MRI, a non-invasive ...

For the study, the investigators randomised people at high risk of asthma or COPD attack into three groups, one receiving benralizumab injection and dummy tablets, one receiving standard of care ...

哮喘和慢性阻塞性肺病（COPD）是常见且致命的呼吸道疾病，每年夺走全球数百万人生命。然而，急性发作时治疗50年来几乎没有进步。近期伦敦国王学院（King′s College London）发表在《柳叶刀呼吸医学》（The Lancet ...

"Medical Journeys" chart a path each step of the way for physicians and patients and provide continual resources and support, as the caregiver team navigates the course of a disease." Recent advances ...

More than 50% of patients with severe asthma have high eosinophil levels, making them candidates for biologic therapies like Nucala and other drugs like AstraZeneca’s Fasenra (benralizumab ...